Literature DB >> 23186370

Prevalence and risk factors of asymptomatic bacteriuria among pregnant Nigerians infected with HIV.

Oliver C Ezechi1, Chidinma V Gab-Okafor, David A Oladele, Olufunto O Kalejaiye, Bamidele O Oke, Sabdat O Ekama, Rosemary A Audu, Rosemary N Okoye, Innocent A O Ujah.   

Abstract

OBJECTIVE: There are conflicting report on the association of HIV infection and asymptomatic bacteriuria (ASB). Most of these studies were from areas with low HIV burden. This study determined the prevalence and risk factors of ASB in HIV positive pregnant women.
METHODS: A cross sectional study among HIV positive pregnant women seen at a large PMTCT clinic in Lagos Nigeria. The women were evaluated for ASB at first clinic attendance. Blood samples were also collected for viral load, CD4 count and hemoglobin levels assessment. Data were managed with SPSS for windows version 19.
RESULTS: 102 (18.1%) women out of 563 studied were found positive for asymptomatic bacteriuria. Ninety-seven (95.1%) of the positive samples yielded single bacterial isolates. Escherichia coli (44.3%) and Proteus mirabilis (21.6%) were the most common bacterial isolates. Previous urinary tract infection (OR: 4.3), HIV-1 RNA greater than 10,000 copies/ml (OR: 3.9), CD4 count <200 cells/mm3 (OR: 1.4) and maternal hemoglobin <11 g/dl (OR: 1.4) were factors significantly associated with ASB after controlling for possible confounders.
CONCLUSION: ASB is common in HIV positive pregnant women in our environment and is associated with previous UTI, high viral load, low CD4 count and maternal hemoglobin <11 g/dl.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23186370     DOI: 10.3109/14767058.2012.733782

Source DB:  PubMed          Journal:  J Matern Fetal Neonatal Med        ISSN: 1476-4954


  7 in total

1.  Detection of bacteriuria among human immunodeficiency virus seropositive individuals in Osogbo, south-western Nigeria.

Authors:  O A Olowe; B B Ojo-Johnson; O B Makanjuola; R A Olowe; V O Mabayoje
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2015-03-26

2.  Antibiotics for asymptomatic bacteriuria in pregnancy.

Authors:  Fiona M Smaill; Juan C Vazquez
Journal:  Cochrane Database Syst Rev       Date:  2019-11-25

3.  Urinary pathogenic bacterial profile, antibiogram of isolates and associated risk factors among pregnant women in Ambo town, Central Ethiopia: a cross-sectional study.

Authors:  Yonas Alem Gessese; Dereje Leta Damessa; Mebratenesh Mengistu Amare; Yonas Hailesilassie Bahta; Assalif Demisew Shifera; Fikreslasie Samuel Tasew; Endrias Zewdu Gebremedhin
Journal:  Antimicrob Resist Infect Control       Date:  2017-12-29       Impact factor: 4.887

4.  Urinary Tract Infections among HIV-Positive Pregnant Women in Mwanza City, Tanzania, Are High and Predicted by Low CD4+ Count.

Authors:  Tito Chaula; Jeremiah Seni; Nhandi Ng'walida; Alphaxaid Kajura; Mariam M Mirambo; Rebekah DeVinney; Stephen E Mshana
Journal:  Int J Microbiol       Date:  2017-01-31

5.  Bacterial Profile and asymptomatic bacteriuria among pregnant women in Africa: A systematic review and meta analysis.

Authors:  Nefsu Awoke; Tiwabwork Tekalign; Mistre Teshome; Tsegaye Lolaso; Getahun Dendir; Mohammed Suleiman Obsa
Journal:  EClinicalMedicine       Date:  2021-06-09

6.  Magnitude and associated factors of urinary tract infections among adults living with HIV in Ethiopia. Systematic review and meta-analysis.

Authors:  Molla Yigzaw Birhanu; Samuel Derbie Habtegiorgis; Wodaje Gietaneh; Simegn Alemu; Tesfa Birlew Tsegaye; Getamesay Molla Bekele; Abtie Abebaw; Tebelay Dilnessa; Haymanot Tewabe Elmneh; Haile Amha; Daniel Bekele Ketema; Tsige Gebre Anto; Melaku Desta; Selamawit Shita Jemberie
Journal:  PLoS One       Date:  2022-04-01       Impact factor: 3.240

7.  Detection of tem-1 and class-1 integrons in multidrug resistant uropathogens from HIV patients with asymptomatic bacteriuria in a Tertiary Care Hospital, SouthWest Nigeria.

Authors:  Olubisi Ajala; Babatunde Odetoyin; Temilola Owojuyigbe; Adebola Onanuga
Journal:  Afr Health Sci       Date:  2022-03       Impact factor: 1.108

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.